CA-125 is useful for a variety of applications, including detection, prognostic, and post-treatment monitoring of disorders such as breast cancer, ovarian cancer, gastrointestinal carcinoma, and lymphoma [306,307,308]. This evidence concerns the gene MUC16 and ovarian cancer.